Journal of Antimicrobial Chemotherapy (1996) 37, 351-356
© 1996 The British Society for Antimicrobial Chemotherapy
brief-report |
Mutations of the gyrA gene of clinical isolates of Salmonella typhimurium and three other Salmonella species leading to decreased susceptibilities to 4-quinolone drugs
Department of Medical Microbiology, The Medical School, University of Edinburgh Teviot Place, Edinburgh EH8 9AG, UK
Received 19 April 1995; returned 15 August 1995; accepted 27 September 1995
*Corresponding author
The region of the gyrA gene encoding nucleotides 72 to 557 in ten Salmonella tvphimurium clinical isolates received from Vellore, India and six British clinical isolates of a number of Salmonella species has been sequenced. Those exhibiting a decreased susceptibility to 4-quinolone drugs (MICs of ciprofloxacin ranging from 0.128 mg/L to 1.0 mg/L) have been shown to possess a number of different mutations in this region of the gene (Asp-87 to Gly, Asp-87 to Asn and Ser-83 to Phe). The mutations Asp-87 to Gly and Ser-83 to Phe/Asp-87 to Asn have yet to be reported occurring in S. typhimurium
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
J. Zheng, S. Cui, and J. Meng Effect of transcriptional activators RamA and SoxS on expression of multidrug efflux pumps AcrAB and AcrEF in fluoroquinolone-resistant Salmonella Typhimurium J. Antimicrob. Chemother., January 1, 2009; 63(1): 95 - 102. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Hakanen, M. Lindgren, P. Huovinen, J. Jalava, A. Siitonen, and P. Kotilainen New Quinolone Resistance Phenomenon in Salmonella enterica: Nalidixic Acid-Susceptible Isolates with Reduced Fluoroquinolone Susceptibility J. Clin. Microbiol., November 1, 2005; 43(11): 5775 - 5778. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. M. Kristiansen, D. Sandvang, and T. B. Rasmussen In Vivo Development of Quinolone Resistance in Salmonella enterica Serotype Typhimurium DT104 J. Clin. Microbiol., September 1, 2003; 41(9): 4462 - 4464. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Hakanen, P. Kotilainen, J. Jalava, A. Siitonen, and P. Huovinen Detection of Decreased Fluoroquinolone Susceptibility in Salmonellas and Validation of Nalidixic Acid Screening Test J. Clin. Microbiol., November 1, 1999; 37(11): 3572 - 3577. [Abstract] [Full Text] |
||||
![]() |
E. Giraud, A. Brisabois, J.-L. Martel, and E. Chaslus-Dancla Comparative Studies of Mutations in Animal Isolates and Experimental In Vitro- and In Vivo-Selected Mutants of Salmonella spp. Suggest a Counterselection of Highly Fluoroquinolone-Resistant Strains in the Field Antimicrob. Agents Chemother., September 1, 1999; 43(9): 2131 - 2137. [Abstract] [Full Text] |
||||
![]() |
J. Ruiz, L. Capitano, L. Nunez, D. Castro, J. M. Sierra, M. Hatha, J. J. Borrego, and J. Vila Mechanisms of resistance to ampicillin, chloramphenicol and quinolones in multiresistant Salmonella typhimurium strains isolated from fish J. Antimicrob. Chemother., May 1, 1999; 43(5): 699 - 702. [Abstract] [Full Text] [PDF] |
||||


